.jpg?format=webp&width=780)
The study evaluated 322 patients with high genetic risk of PCa and assessed different diagnostic markers and scenarios for managing early diagnosis of cancer. The results indicate that mpMRI with a PI-RADS score ≥3 is more sensitive for detecting PCa and clinically significant PCa compared to PSA level screening. Pre-screening with PSA level may result in missing high-grade tumors and unnecessary biopsies. In cases of negative mpMRI, the study suggests using urinary markers or PSAD of ≥0.10 ng/mL/mL to increase the detection of high-grade cancers. The study recommends a baseline mpMRI for men at high genetic risk from the age of 40 years.
Like
Save
Share